
Director Global Oncology Market Access - SacTMT
Merck
Summary
The Director, Oncology Global Market Access will lead global market access strategy for one or more indications of the Company's antibody drug conjugate program, Sac-TMT, working across development and commercialization to optimize patient access and long-term value.
Job description
Primary Responsibilities
- Lead global market access strategy for assigned indications, from clinical development through launch planning and commercialization.
- Develop clear, decision-ready recommendations that connect market access, pricing, evidence, clinical development, and commercial implications.
- Provide strategic market access input into clinical development and evidence-generation decisions, including patient population, endpoints, comparators, treatment setting, sequencing, evidence gaps, and other factors that may influence future payer value assessment and access.
- Lead continued development and evolution of the Global Plan for Access, ensuring key access risks, opportunities, evidence requirements, and market archetype considerations are incorporated into asset strategy.
- Identify core value drivers and challenges to support value recognition and inform asset-level pricing strategy.
- Lead global market access input to launch readiness and indication-expansion planning, identifying potential access barriers early and developing strategies to address them.
- Partner with U.S., regional, and local market access organizations to incorporate critical market realities into global strategy.
- Assess payer trends, health technology assessment requirements, competitor developments, policy changes, pricing dynamics, and other external developments that could affect access or asset value.
- Translate complex analyses and perspectives from multiple markets and functions into clear strategic choices and strong recommendations.
- Represent Global Market Access in cross-functional teams and governance discussions.
- Lead or coordinate market access analyses including payer research, access scenario planning, forecast assumptions, launch sequencing, and risk/opportunity assessments.
- Communicate recommendations effectively to senior leaders and governance forums through concise presentations and compelling, evidence-based storytelling.
Qualifications
- BA/BS in Business, Science, Health Economics, Public Health, or a related discipline.
- Minimum of 5 years of relevant experience in market access, pricing and reimbursement, biopharma-related management consulting, health economics/outcomes research, commercial strategy, or related areas.
- Strong understanding of biopharma business model, product development, commercialization, pricing, reimbursement, and payer decision making.
- Experience with, or strong familiarity with, the U.S. market combined with broader global market access exposure.
- Demonstrated ability to translate complex quantitative and qualitative analyses into clear strategic recommendations.
- Strong commercial orientation, analytical capability, and business acumen.
- Excellent written and verbal communication skills.
- Experience leading complex cross-functional initiatives within a matrixed organization.
- Strong stakeholder management, collaboration, and influencing skills.
- Ability to exercise sound strategic judgment and drive progress in ambiguous, rapidly evolving situations.
Preferred Qualifications
- Advanced degree such as MBA, MPH, MS, PharmD, PhD, or other relevant postgraduate qualification.
- Significant oncology market access and/or oncology commercialization experience.
- Experience influencing clinical development or evidence-generation strategy from a market access perspective.
- Experience developing global pricing strategies and supporting price, access, or revenue forecasting.
- Experience supporting oncology launches or indication expansions across multiple major markets.
- Experience presenting recommendations to senior leadership or enterprise governance bodies.
- Consulting experience or equivalent strength in structured problem solving, analytics, synthesis, and executive storytelling.
Requirements
- BA/BS in Business, Science, Health Economics, Public Health, or a related discipline
- Minimum of 5 years of relevant experience in market access, pricing and reimbursement, biopharma-related management consulting, health economics/outcomes research, commercial strategy, or related areas
- Strong understanding of biopharma business model, product development, commercialization, pricing, reimbursement, and payer decision making
- Experience with, or strong familiarity with, the U.S. market combined with broader global market access exposure
- Demonstrated ability to translate complex quantitative and qualitative analyses into clear strategic recommendations
- Strong commercial orientation, analytical capability, and business acumen
- Excellent written and verbal communication skills
- Experience leading complex cross-functional initiatives within a matrixed organization
- Strong stakeholder management, collaboration, and influencing skills
- Ability to exercise sound strategic judgment and drive progress in ambiguous, rapidly evolving situations
Benefits
- Medical, Dental & Vision
- 401(k) Retirement Benefits
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.